In the first episode of Pharma Unplugged we take a look at the recent FDA hearing on social media and what it means for the drug industry.
A Link Apart : FDA Social Media Hearing
Download Adobe Flash Player
Patient Segmentation Strategies
WEBCAST – Sponsor (Medpoint)
How Virtual Media Can Save the Medical Speaker Program
WEBCAST – Sponsor (Healthgrades)
Driving Medication Compliance
PODCAST – Sponsor (AdherenceRx)
Topic:
(Nov 23, 2009) Think you’ve heard enough about the FDA Social Media Hearing held earlier this month. Granted, the gaggle of general and industry coverage was way more than one person can digest. So we asked four experts who spoke at the hearings to sit down with us and debate the issues. With so much at stake and so little clarity, we hope this hour long panel interview will help you figure out what it all means to you and your business.
Host:
George Koroneos, Online/News Editor: Pharmaceutical Executive
Panel:
Fabio Gratton, founder, Ignite Health
Fard Johnmar, founder, Envision Solutions
Bruce Grant, SVP, Business Strategy, Digitas Health
Bill Drummy, founder and CEO, Heartbeat Digital
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.